2
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
34
Squamous Cell Carcinoma of Head and Neck
22
Uterine Cervical Neoplasms
19
Lung Neoplasms
19
Small Cell Lung Carcinoma
16
Oropharyngeal Neoplasms
14
Ovarian Neoplasms
12
Carcinoma
10
Urinary Bladder Neoplasms
9
Stomach Neoplasms
9
Mouth Neoplasms
9
Laryngeal Neoplasms
9
Fallopian Tube Neoplasms
9
Hypopharyngeal Neoplasms
8
Mesothelioma, Malignant
7
Medulloblastoma
7
Cholangiocarcinoma
7
Breast Neoplasms
7
Adenocarcinoma of Lung
7
Pancreatic Neoplasms
6
Neuroblastoma
6
Nasopharyngeal Carcinoma
6
Gallbladder Neoplasms
6
Ganglioneuroblastoma
5
Brain Neoplasms
5
Triple Negative Breast Neoplasms
4
Prostatic Neoplasms
4
Lymphoid Interstitial Pneumonia
4
Head and Neck Neoplasms
4
Esophageal Neoplasms
4
Interventions
Fluorouracil
219
Leucovorin
202
Oxaliplatin
192
Irinotecan
150
Bevacizumab
110
Capecitabine
94
Cetuximab
90
Folfox protocol
54
Chemotherapy, Adjuvant
36
Panitumumab
30
Colonoscopy
30
pembrolizumab
23
Drug Therapy
23
Nivolumab
22
Magnetic Resonance Spectroscopy
22
Gemcitabine
21
Blood Specimen Collection
20
Radiotherapy
19
Floxuridine
19
Biopsy
19
Neoadjuvant Therapy
18
Laparoscopy
18
IFL protocol
18
Early Intervention, Educational
18
Celecoxib
18
Surveys and Questionnaires
17
Surgical Procedures, Operative
16
Immunohistochemistry
16
Exercise
16
trifluridine tipiracil drug combination
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Platinum
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled